Cyclodextrin News

July 17, 2019 Pharma applications

Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated announced positive top line results from a Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol

July 9, 2019 CD as API / Events / Pharma applications

National Niemann Pick Disease Family Conference

The annual National Niemann Pick Disease Family Conference will be held on August 15-18, 2019, in Bloomington, US. The conference

July 6, 2019 Analysis / Drug delivery / Pharma applications

International Congress and Exhibition on Pharmacy

The International Congress and Exhibition on Pharmacy will be held on 15–16 August, 2019, in Prague, Czech Republic. The motto

July 4, 2019 Non-pharma applications / Pharma applications

World Cyclodextrin Market Research Report 2024

The report covering USA, EU, China, South East Asia, India, Japan and etc) can provide the deep insights of the

July 2, 2019 CD as API / Pharma applications

Methyl-β-cyclodextrin, an actin depolymerizer augments the antiproliferative potential of microtubule-targeting agents

The effect of Methyl BCD (RAMEB) on cytoskeleton was studied. It was found that disassembling the actin network did not

June 27, 2019 Events / Pharma applications

International Pharmacology and Pharmaceutical Sciences Conference

“International Pharmacology and Pharmaceutical Sciences Conference (OLCPPSC-2019)” will be held at Venice, Italy during November 14-15, 2019. This conference have

June 26, 2019 CD as API / CD derivatives / Pharma applications

Clinical trial on Noninfectious Anterior Uveitis – SBECD offering disease resolution

Aldeyra Therapeutics Announced Results from the SOLACE Trial in Noninfectious Anterior Uveitis. The main points are: Statistical Significance Not Achieved